We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Alphatec (ATEC) Moves 12.8% Higher: Will This Strength Last?
Read MoreHide Full Article
Alphatec (ATEC - Free Report) shares soared 12.8% in the last trading session to close at $12.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 3.1% loss over the past four weeks.
Alphatec recorded a solid price appreciation driven by its encouraging preliminary fourth quarter and full-year 2021 financial results, coupled with a strong 2022 outlook. Per the pre-announcement, the company reported fourth quarter revenues in the range of $73.2-$74.0 million and full-year 2021 revenues in the band of $242.5-$243.3 million both ahead of the respective Zacks Consensus Estimates of $66.59 million and $236.16 million. The company’s projected full-year 2022 total revenue of $305 million (up 26% year over year) raises investors’ optimism. The Zacks Consensus Estimate for Alphatec’s 2022 revenues is pegged at $292.12 million, below the company’s projection.
This medical equipment and supplies holding company is expected to post quarterly loss of $0.30 per share in its upcoming report, which represents a year-over-year change of -36.4%. Revenues are expected to be $66.59 million, up 51.5% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Alphatec, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on ATEC going forward to see if this recent jump can turn into more strength down the road.
Image: Bigstock
Alphatec (ATEC) Moves 12.8% Higher: Will This Strength Last?
Alphatec (ATEC - Free Report) shares soared 12.8% in the last trading session to close at $12.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 3.1% loss over the past four weeks.
Alphatec recorded a solid price appreciation driven by its encouraging preliminary fourth quarter and full-year 2021 financial results, coupled with a strong 2022 outlook. Per the pre-announcement, the company reported fourth quarter revenues in the range of $73.2-$74.0 million and full-year 2021 revenues in the band of $242.5-$243.3 million both ahead of the respective Zacks Consensus Estimates of $66.59 million and $236.16 million. The company’s projected full-year 2022 total revenue of $305 million (up 26% year over year) raises investors’ optimism. The Zacks Consensus Estimate for Alphatec’s 2022 revenues is pegged at $292.12 million, below the company’s projection.
This medical equipment and supplies holding company is expected to post quarterly loss of $0.30 per share in its upcoming report, which represents a year-over-year change of -36.4%. Revenues are expected to be $66.59 million, up 51.5% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Alphatec, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on ATEC going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>